Clinical Trial Update: RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing reduced-intensity conditioned allogeneic stem cell transplant against venetoclax-based consolidation in elderly patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: He Huang | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: RECRUITING